High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury

Journal of Vascular Surgery

Volumn 55, Issue 1, 2012, Pages 180-191

  Sachdev, Ulka ^a   Cui, Xiangdong ^a   Hong, Guiying ^a   Namkoong, Seung ^a   Karlsson, Jenny M ^b   Baty, Catherine J ^b   Tzeng, Edith ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; CHLOROQUINE; HIGH MOBILITY GROUP B1 PROTEIN; LIGHT CHAIN 3I; MYOSIN LIGHT CHAIN; RAPAMYCIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOPHAGY; CELL COUNT; CELL DENSITY; CELL FUNCTION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LASER DOPPLER FLOWMETRY; LASER DOPPLER PERFUSION IMAGING; LIMB ISCHEMIA; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MUSCLE FIBRIL; MUSCLE REGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; WESTERN BLOTTING;

EID: 83955162908     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.07.072     Document Type: Article

References (38)

1. E. Selvin, T.P. Erlinger Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000 Circulation 110 2004 738 743
2. W.A. Marston, S.W. Davies, B. Armstrong, M.A. Farber, R.C. Mendes, J.J. Fulton Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization J Vasc Surg 44 2006 108 114
3. L.M. Messina, L.S. Brevetti, D.S. Chang, R. Paek, R. Sarkar Therapeutic angiogenesis for critical limb ischemia: invited commentary J Control Release 78 2002 285 294
4. R.J. Powell, J. Dormandy, M. Simons, R. Morishita, B.H. Annex Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial Vasc Med 9 2004 193 198
5. I. Masaki, Y. Yonemitsu, A. Yamashita, S. Sata, M. Tanii, K. Komori Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2 Circ Res 90 2002 966 973
6. R.K. Jain Molecular regulation of vessel maturation Nat Med 9 2003 685 693
7. P. Baluk, C.G. Lee, H. Link, E. Ator, A. Haskell, J.A. Elias Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways Am J Pathol 165 2004 1071 1085
8. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936
9. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395
10. S. Frantz, K.A. Vincent, O. Feron, R.A. Kelly Innate immunity and angiogenesis Circ Res 96 2005 15 26
11. U. Fiedler, Y. Reiss, M. Scharpfenecker, V. Grunow, S. Koidl, G. Thurston Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation Nat Med 12 2006 235 239
12. A. Albini, C. Brigati, A. Ventura, G. Lorusso, M. Pinter, M. Morini Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target J Transl Med 7 2009 5
13. M.T. Lotze, K.J. Tracey High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331 342
14. H. Yang, H. Wang, C.J. Czura, K.J. Tracey The cytokine activity of HMGB1 J Leukoc Biol 78 2005 1 8
15. I.E. Dumitriu, P. Baruah, A.A. Manfredi, M.E. Bianchi, P. Rovere-Querini HMGB1: guiding immunity from within Trends Immunol 26 2005 381 387
16. M.E. Bianchi HMGB1 loves company J Leukoc Biol 86 2009 573 576
17. A. Tsung, R. Sahai, H. Tanaka, A. Nakao, M.P. Fink, M.T. Lotze The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 2005 1135 1143
18. H. Wang, O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
19. K.P. Mollen, R.M. Levy, J.M. Prince, R.A. Hoffman, M.J. Scott, D.J. Kaczorowski Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells J Leukoc Biol 83 2008 80 88
20. R.M. Levy, K.P. Mollen, J.M. Prince, D.J. Kaczorowski, R. Vallabhaneni, S. Liu Systemic inflammation and remote organ injury following trauma require HMGB1 Am J Physiol Regul Integr Comp Physiol 293 2007 R1538 R1544
21. S. Mitola, M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine J Immunol 176 2006 12 15
22. D. Tang, R. Kang, K.M. Livesey, C.W. Cheh, A. Farkas, P. Loughran Endogenous HMGB1 regulates autophagy J Cell Biol 190 2010 881 892
23. C. Ngamkitidechakul, S.S. Twining Buffered non-fermenter system for lab-scale production of secreted recombinant His-tagged proteins in Saccharomyces cerevisiae Biotechniques 33 2002 1296 1300
24. H. Yang, M. Ochani, J. Li, X. Qiang, M. Tanovic, H.E. Harris Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci U S A 101 2004 296 301
25. D. Bae, S. Lu, C.A. Taglienti, A.M. Mercurio Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2 J Biol Chem 283 2008 28074 28080
26. R. De Mori, S. Straino, A. Di Carlo, A. Mangoni, G. Pompilio, R. Palumbo Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration Arterioscler Thromb Vasc Biol 27 2007 2377 2383
27. J.R. van Beijnum, R.P. Dings, E. van der Linden, B.M. Zwaans, F.C. Ramaekers, K.H. Mayo Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature Blood 108 2006 2339 2348
28. C. Schlueter, H. Weber, B. Meyer, P. Rogalla, K. Roser, S. Hauke Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule Am J Pathol 166 2005 1259 1263
29. C.L. Zhang, M.G. Shu, H.W. Qi, L.W. Li Inhibition of tumor angiogenesis by HMGB1 A box peptide Med Hypotheses 70 2008 343 345
30. F. Biscetti, G. Straface, R. De Cristofaro, S. Lancellotti, P. Rizzo, V. Arena High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism Diabetes 59 2010 1496 1505
31. H. Wake, S. Mori, K. Liu, H.K. Takahashi, M. Nishibori Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay Eur J Pharmacol 623 2009 89 95
32. L.L. Rong, S.F. Yan, T. Wendt, D. Hans, S. Pachydaki, L.G. Bucciarelli RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways FASEB J 18 2004 1818 1825
33. D. Tang, R. Kang, W. Xiao, H. Zhang, M.T. Lotze, H. Wang Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function Am J Respir Cell Mol Biol 41 2009 651 660
34. P.O. Seglen, P.B. Gordon 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes Proc Natl Acad Sci U S A 79 1982 1889 1892
35. K. Shigemitsu, Y. Tsujishita, K. Hara, M. Nanahoshi, J. Avruch, K. Yonezawa Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways J Biol Chem 274 1999 1058 1065
36. J. Thorburn, A.E. Frankel, A. Thorburn Regulation of HMGB1 release by autophagy Autophagy 5 2009 247 249
37. T. Ogata, Y. Oishi, M. Higuchi, I. Muraoka Fasting-related autophagic response in slow- and fast-twitch skeletal muscle Biochem Biophys Res Commun 394 2010 136 140
38. M. Sandri Autophagy in skeletal muscle FEBS Lett 584 2010 1411 1416